rs56233104
Positions:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BA1
The NM_002253.4(KDR):c.-1G>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0499 in 1,611,238 control chromosomes in the GnomAD database, including 2,284 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.037 ( 142 hom., cov: 33)
Exomes 𝑓: 0.051 ( 2142 hom. )
Consequence
KDR
NM_002253.4 5_prime_UTR
NM_002253.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.94
Genes affected
KDR (HGNC:6307): (kinase insert domain receptor) Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 4-55125294-C-A is Benign according to our data. Variant chr4-55125294-C-A is described in ClinVar as [Benign]. Clinvar id is 135552.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr4-55125294-C-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0558 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDR | NM_002253.4 | c.-1G>T | 5_prime_UTR_variant | 1/30 | ENST00000263923.5 | NP_002244.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDR | ENST00000263923.5 | c.-1G>T | 5_prime_UTR_variant | 1/30 | 1 | NM_002253.4 | ENSP00000263923 | P1 | ||
KDR | ENST00000512566.1 | upstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0371 AC: 5641AN: 152218Hom.: 142 Cov.: 33
GnomAD3 genomes
AF:
AC:
5641
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0368 AC: 8907AN: 241940Hom.: 199 AF XY: 0.0370 AC XY: 4873AN XY: 131526
GnomAD3 exomes
AF:
AC:
8907
AN:
241940
Hom.:
AF XY:
AC XY:
4873
AN XY:
131526
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0512 AC: 74751AN: 1458902Hom.: 2142 Cov.: 32 AF XY: 0.0502 AC XY: 36439AN XY: 725528
GnomAD4 exome
AF:
AC:
74751
AN:
1458902
Hom.:
Cov.:
32
AF XY:
AC XY:
36439
AN XY:
725528
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0370 AC: 5643AN: 152336Hom.: 142 Cov.: 33 AF XY: 0.0340 AC XY: 2530AN XY: 74502
GnomAD4 genome
AF:
AC:
5643
AN:
152336
Hom.:
Cov.:
33
AF XY:
AC XY:
2530
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
KDR-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 23, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at